Ironwood Pharmaceuticals, Inc.

IRWD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.46-1.14%

2026-11-02

Financials

Valuation Metrics

Ironwood Pharmaceuticals, Inc.'s Market Cap is $570M. At end of 2025 it was $547M. Ranked #2684 of 3,118 in US market (top 86%), #1160 of 1,474 on NASDAQ (top 79%), #208 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 78%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$570M	US#2,684/3,118 Sec#208/265
Revenue	$389M	US#2,336/3,118 Sec#87/265
Net Income	$130M	US#1,507/3,118 Sec#51/265
Total Assets	$285M	US#2,911/3,118 Sec#212/265
Net Assets	$-162M	US#2,965/3,118 Sec#252/265
Value
P/E	4.39x	US#42/3,118 Sec#4/265
P/S	1.46x	US#1,023/3,118 Sec#17/265
EV/EBITDA	3.68x	US#88/3,118 Sec#7/265
FCF Yield	32.58%	US#79/3,118 Sec#4/265
Profitability
ROA	45.55%	US#12/3,118 Sec#4/265
Op. Margin	60.64%	US#67/3,118 Sec#3/265
Revenue Growth	26.19%	US#485/3,118 Sec#65/265
Financial Health
Total Debt	$397M	US#1,987/3,118 Sec#72/265
FCF	$186M	US#1,418/3,118 Sec#48/265
Cash	$79M	US#2,349/3,118 Sec#193/265
Current Ratio	6.06x	US#386/3,118 Sec#121/265
Net Debt/EBITDA	1.32x	US#1,094/3,118 Sec#47/265
Performance
1Y Return	80.21%	US#78/3,118 Sec#24/265
1M Return	-4.95%	US#2,530/3,118 Sec#188/265
From 52W High	-40.14%	US#2,322/3,118 Sec#167/265
1Y MDD	-43.60%	US#2,103/3,118 Sec#138/265
Trading
Volume	1,274,758 shares	US#1,219/3,118 Sec#116/265
Trading Value	$4M	US#2,616/3,118 Sec#209/265
Per Share
EPS	$0.79	US#1,745/3,118 Sec#52/265
BPS	$-0.98	US—/3,118 Sec—/265